These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8054483

  • 21. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
    Gearing DP, Ziegler SF, Comeau MR, Friend D, Thoma B, Cosman D, Park L, Mosley B.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):1119-23. PubMed ID: 8302840
    [Abstract] [Full Text] [Related]

  • 22. Expression of a fusion protein of human ciliary neurotrophic factor and soluble CNTF-receptor and identification of its activity.
    Sun Y, Pia M, Uwe O, Ge JG, Stefan RJ.
    J Zhejiang Univ Sci; 2003 Feb 01; 4(3):340-5. PubMed ID: 12765290
    [Abstract] [Full Text] [Related]

  • 23. Differential response of neuronal cells to a fusion protein of ciliary neurotrophic factor/soluble CNTF-receptor and leukemia inhibitory factor.
    März P, Ozbek S, Fischer M, Voltz N, Otten U, Rose-John S.
    Eur J Biochem; 2002 Jun 01; 269(12):3023-31. PubMed ID: 12071967
    [Abstract] [Full Text] [Related]

  • 24. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S.
    Eur J Biochem; 2001 Jan 01; 268(1):160-7. PubMed ID: 11121117
    [Abstract] [Full Text] [Related]

  • 25. Cytokines that use gp130 as a signal transducer stimulate mouse placental lactogen-I (mPL-I) but inhibit mPL-II production in vitro.
    Yamaguchi M, Taga T, Kishimoto T, Miyake A.
    Biol Reprod; 1995 Aug 01; 53(2):399-406. PubMed ID: 7492693
    [Abstract] [Full Text] [Related]

  • 26. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P.
    FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
    Nishimoto N, Ogata A, Shima Y, Tani Y, Ogawa H, Nakagawa M, Sugiyama H, Yoshizaki K, Kishimoto T.
    J Exp Med; 1994 Apr 01; 179(4):1343-7. PubMed ID: 8145046
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG.
    Oncogene; 1996 Feb 01; 12(3):585-93. PubMed ID: 8637716
    [Abstract] [Full Text] [Related]

  • 33. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL, Ward LD, Tu GF, Fabri LJ, Ji H, Yasukawa K, Simpson RJ.
    Growth Factors; 1999 Feb 01; 16(4):265-78. PubMed ID: 10427501
    [Abstract] [Full Text] [Related]

  • 34. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
    Gyotoku E, Morita E, Kameyoshi Y, Hiragun T, Yamamoto S, Hide M.
    Arch Dermatol Res; 2001 Nov 01; 293(10):508-14. PubMed ID: 11820727
    [Abstract] [Full Text] [Related]

  • 35. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.
    Benigni F, Fantuzzi G, Sacco S, Sironi M, Pozzi P, Dinarello CA, Sipe JD, Poli V, Cappelletti M, Paonessa G, Pennica D, Panayotatos N, Ghezzi P.
    Blood; 1996 Mar 01; 87(5):1851-4. PubMed ID: 8634432
    [Abstract] [Full Text] [Related]

  • 36. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    Int Immunol; 1996 Apr 01; 8(4):595-602. PubMed ID: 8722639
    [Abstract] [Full Text] [Related]

  • 37. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
    Palmqvist P, Persson E, Conaway HH, Lerner UH.
    J Immunol; 2002 Sep 15; 169(6):3353-62. PubMed ID: 12218157
    [Abstract] [Full Text] [Related]

  • 38. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
    Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N.
    Cancer; 1999 Jan 01; 85(1):134-44. PubMed ID: 9921985
    [Abstract] [Full Text] [Related]

  • 39. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis.
    Tacken I, Dahmen H, Boisteau O, Minvielle S, Jacques Y, Grötzinger J, Küster A, Horsten U, Blanc C, Montero-Julian FA, Heinrich PC, Müller-Newen G.
    Eur J Biochem; 1999 Oct 01; 265(2):645-55. PubMed ID: 10504396
    [Abstract] [Full Text] [Related]

  • 40. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein.
    Gimble JM, Wanker F, Wang CS, Bass H, Wu X, Kelly K, Yancopoulos GD, Hill MR.
    J Cell Biochem; 1994 Jan 01; 54(1):122-33. PubMed ID: 8126083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.